JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoos, J. R.
Right arrow Articles by Kopacz, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoos, J. R.
Right arrow Articles by Kopacz, D. J.

Anesth Analg 2005;100:553-558
© 2005 International Anesthesia Research Society
doi: 10.1213/01.ANE.0000130397.38849.4A


REGIONAL ANESTHESIA

Spinal 2-Chloroprocaine for Surgery: An Initial 10-Month Experience

Jessica R. Yoos, MD, and Dan J. Kopacz, MD

Department of Anesthesiology, Virginia Mason Clinic, Seattle, Washington

Spinal 2-chloroprocaine (2-CP) is currently being investigated as a short-acting alternative to lidocaine, which frequently causes transient neurologic symptoms (TNS) in surgical patients. TNS has not been reported with 2-CP in volunteers in doses ranging from 30 to 60 mg and appears to provide an excellent level of surgical anesthesia. In this retrospective study, we describe the experience with spinal 2-CP in surgical patients during its first 10 mo of clinical use at our institution. Most patients had ambulatory surgery, including 39 orthopedic, 30 general surgical, 18 gynecologic, and 34 genitourinary procedures. Chloroprocaine 30 or 40 mg, with or without fentanyl (10–20 µg), was the most common (92%) dose combination used. Mean peak block height averaged T6 to T8. The surgical procedure time was 32.3 ± 18.4 min. Time from placement of the block to the end of the surgical procedure was 53.1 ± 20.7 min. Times to ambulation and discharge were 155.1 ± 34.7 min and 207.9 ± 69.4 min, respectively. 2-CP spinal anesthesia has proven to be a safe and effective alternative to lidocaine and procaine for ambulatory surgical procedures of ≤1 h, with a predictable regression of block height. No patients reported TNS after surgery.




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
R. K. Baumgarten
Spinal Anesthesia Research: Let's Not Be Hasty
Anesth. Analg., December 1, 2007; 105(6): 1862 - 1862.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
K. Drasner
Chloroprocaine Spinal Anesthesia: Back to the Future?
Anesth. Analg., February 1, 2005; 100(2): 549 - 552.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
B. R. Davis and D. J. Kopacz
Spinal 2-Chloroprocaine: The Effect of Added Clonidine
Anesth. Analg., February 1, 2005; 100(2): 559 - 565.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
J. R. Yoos and D. J. Kopacz
Spinal 2-Chloroprocaine: A Comparison with Small-Dose Bupivacaine in Volunteers
Anesth. Analg., February 1, 2005; 100(2): 566 - 572.
[Abstract] [Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2005 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2005 by the International Anesthesia Research Society.